AI Agents Flood Healthcare at HIMSS 2026, But Validation Concerns Grow

AI Agents Flood Healthcare at HIMSS 2026, But Validation Concerns Grow

The HIMSS 2026 health IT conference brought a wave of AI agent announcements from the largest players in healthcare technology. Epic Systems, Google, Microsoft, and Oracle all showcased new agentic tools designed to automate clinical workflows — but experts attending the conference warned that products are reaching patients before sufficient validation has occurred.

Epic's AI Agent Lineup

Epic Systems touted three newly launched AI agents now operating within its platform:

• Art takes faster notes and drafts medical documentation, reducing physician time spent on administrative tasks.
• Penny helps hospitals collect bills and avoid insurance coverage denials.
• Emmie answers patient questions and assists with appointment scheduling.

Epic also announced that more than 85% of its customers are now using Epic AI in some form, alongside forthcoming capabilities including conversational AI for clinicians, an AI agent factory, and differential diagnosis support.

The Validation Problem

Clinicians and researchers at the conference pushed back on the pace of deployment. Multiple speakers noted that AI agents are proliferating in healthcare faster than they can be counted — let alone tested with real patients across diverse clinical settings. The core concern is that healthcare AI products are being adopted based on vendor demonstrations rather than independent evidence of safety and efficacy.

The debate mirrors broader tensions in healthcare AI over the past two years: tools powered by large language models can perform impressively in controlled settings but may behave unpredictably in edge cases that matter most in clinical care.